alpha-ergocryptine has been researched along with methiothepin in 1 studies
| Studies (alpha-ergocryptine) | Trials (alpha-ergocryptine) | Recent Studies (post-2010) (alpha-ergocryptine) | Studies (methiothepin) | Trials (methiothepin) | Recent Studies (post-2010) (methiothepin) |
|---|---|---|---|---|---|
| 74 | 1 | 8 | 494 | 2 | 62 |
| Protein | Taxonomy | alpha-ergocryptine (IC50) | methiothepin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | 0.0075 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boess, FG; Monsma, FJ; Sleight, AJ | 1 |
1 other study(ies) available for alpha-ergocryptine and methiothepin
| Article | Year |
|---|---|
Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
Topics: Adenylyl Cyclases; Amino Acid Substitution; Binding Sites; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Ligands; Lysergic Acid Diethylamide; Mutagenesis, Site-Directed; Mutation; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1998 |